Joint (JYNT) Expected to Announce Earnings on Thursday

Joint (NASDAQ:JYNT) is expected to be releasing its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect Joint to post earnings of ($0.01) per share and revenue of $13.36 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Thursday, November 6, 2025 at 5:00 PM ET.

Joint (NASDAQ:JYNT) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. Joint had a negative net margin of 7.02% and a positive return on equity of 0.60%. The company had revenue of $13.27 million for the quarter, compared to the consensus estimate of $13.32 million. On average, analysts expect Joint to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Joint Stock Performance

Joint stock opened at $7.89 on Wednesday. The company has a market cap of $121.06 million, a P/E ratio of -23.91 and a beta of 1.45. The firm’s 50-day moving average is $9.35 and its 200-day moving average is $10.37. Joint has a 1 year low of $7.69 and a 1 year high of $13.47.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Joint in a research report on Wednesday, October 8th. B. Riley cut their price objective on shares of Joint from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $16.33.

Insider Buying and Selling

In related news, Director Christopher M. Grandpre bought 14,388 shares of the stock in a transaction on Friday, August 15th. The shares were purchased at an average price of $10.88 per share, with a total value of $156,541.44. Following the purchase, the director owned 19,383 shares in the company, valued at approximately $210,887.04. This represents a 288.05% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Over the last 90 days, insiders have bought 34,388 shares of company stock worth $367,641. 27.90% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Joint

Several large investors have recently bought and sold shares of the stock. JCP Investment Management LLC acquired a new position in Joint during the 2nd quarter valued at about $5,526,000. Topline Capital Management LLC increased its stake in Joint by 18.7% during the 2nd quarter. Topline Capital Management LLC now owns 449,204 shares of the company’s stock valued at $5,184,000 after buying an additional 70,910 shares during the period. Geode Capital Management LLC increased its stake in Joint by 17.6% during the 2nd quarter. Geode Capital Management LLC now owns 345,330 shares of the company’s stock valued at $3,986,000 after buying an additional 51,704 shares during the period. American Century Companies Inc. increased its stake in Joint by 13.9% during the 2nd quarter. American Century Companies Inc. now owns 27,572 shares of the company’s stock valued at $318,000 after buying an additional 3,366 shares during the period. Finally, Rhumbline Advisers grew its stake in shares of Joint by 25.9% in the 2nd quarter. Rhumbline Advisers now owns 20,934 shares of the company’s stock worth $242,000 after purchasing an additional 4,307 shares during the last quarter. Institutional investors and hedge funds own 76.88% of the company’s stock.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.